Home
Interactions
Genes
Downloads
Contact
Slorth
LEF1 - BLM
H. sapiens
SDL interaction
Identifiers
Gene Name
Gene ID
Diseases
Drugs
GO terms
Orthologs
LEF1
ENSG00000138795
B-ALL
T-ALL
eyelid sebaceous carcinoma
AML
lymphomas
No drugs in record
RNA polymerase II regulatory region sequence-specific DNA binding
RNA polymerase II core promoter proximal region sequence-specific DNA binding
transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding
transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding
DNA binding
chromatin binding
transcription factor activity, sequence-specific DNA binding
transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding
protein binding
beta-catenin binding
transcription factor binding
DNA binding, bending
estrogen receptor activity
estrogen receptor binding
enhancer binding
histone binding
histone deacetylase binding
cysteine-type endopeptidase inhibitor activity involved in apoptotic process
sequence-specific DNA binding
transcription regulatory region DNA binding
gamma-catenin binding
armadillo repeat domain binding
C2H2 zinc finger domain binding
pop-1 (C. elegans)
pan (D. melanogaster)
BLM
ENSG00000197299
leukaemia
lymphoma
skin squamous cell
other tumour types
No drugs in record
bubble DNA binding
p53 binding
single-stranded DNA binding
ATP-dependent DNA helicase activity
helicase activity
protein binding
ATP binding
ATP-dependent helicase activity
four-way junction helicase activity
ATPase activity
annealing helicase activity
ATP-dependent 3'-5' DNA helicase activity
G-quadruplex DNA binding
DNA helicase activity
DNA-dependent ATPase activity
Y-form DNA binding
SGS1 (S. cerevisiae)
him-6 (C. elegans)
Blm (D. melanogaster)